PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and ...

Sun Pharmaceutical Industries Ltd. closed 10.75% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

This was the stock's second consecutive day of losses.

Discover Regional Growth Trends and Shares for Galsulfase, Velaglucerase Alfa, Laronidase, Asfotasealfa, and Other ERT ...

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...

The "Crown" logo, PanOxyl and Blue Lizard are registered trademarks of Crown Laboratories, Inc. SkinPen and StriVectin are registered trademarks of Bellus Medical, LLC and StriVectin Operating Company ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...

Here is my annual critical ranking of the Super Bowl commercials. This is the pregame edition, with all the available ...

Company leaders plan to close facilities in Georgia and Tennessee, and reduce staff at another East Tennessee facility.

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 23,785.79 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...